Tenpoint Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTenpoint Therapeutics
Tenpoint Therapeutics logo

Tenpoint Therapeutics

0 followers

About Tenpoint Therapeutics

Tenpoint Therapeutics is an ophthalmology-focused biotech company developing eye treatments aimed at restoring vision in aging eyes. The company emphasizes presbyopia, cataract-related vision issues, and geographic atrophy, partnering with eye care professionals to redefine presbyopia care and improve near-vision performance. Headquartered in London with a global perspective, Tenpoint Therapeutics highlights a pipeline of innovative therapies and a commitment to real-world needs in eye care.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Gabriella Rolli, PhD

Chief Technology Officer, Regenerative Medicine

Henric Bjarke

Chief Executive Officer

Ben Bergo

President, Chief Business Officer

Esther Cuno

Vice President of Human Resources

Melissa Epperly

Chief Financial Officer

Key Facts

HQ Location

London, United Kingdom

Founded

2019

Employees

51 - 200

Status

Private

Website

https://tenpointtherapeutics.com